Dr Chris Rogan at APSCVIR – Through the Cholangio Lens
“This isn’t awareness for awareness’s sake. This is survival — activated, resourced, and built to deliver under pressure.”
— Doctrine: How We Win

CHOLANGIO TODAY: OUR VOICE
Breaks Silence. Spotlights What Works.
One mission — Save More Lives.
By Steve Holmes
This article
a review through our cholangio lens
Source: LinkedIn Post
29th May 2025
Why This Conference Mattered
“Care helps us cope. Response helps us win.”
— SteveH
Dr Chris Rogan attended the Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR) Congress — but not just as a participant. He was there as a leader, educator, and innovator, focusing on one of the most neglected cancers: intrahepatic cholangiocarcinoma (ICC).
For patients, this matters because ICC still receives minimal attention — but Chris is pushing it onto the global stage.
Who is Dr Chris Rogan?
A Quiet Force Moving Beside Us
Dr Chris Rogan doesn’t chase headlines. But if you look closely, you’ll find him at the centre of something powerful: bringing precision treatment options to patients who’ve often been told there are none.
He’s one of those rare clinicians who listens not just to the scans, but to the lives behind them. And while others wait for systems to change, Chris builds what’s missing — quietly, precisely, and with unwavering focus on patient outcomes.
He graduated Medicine from the University of NSW with First Class Honours, trained in surgery, then radiology, and later specialised in minimally invasive, image-guided therapies — known as interventional radiology. After fellowship training at Imperial College London and international placements across the UK and USA, he earned European Board certification in IR. Today, he serves as President of the Interventional Radiology Society of Australasia.
But none of that defines him more than this:
“What motivates me is seeing patients return to life — with fewer scars, faster recovery, and real hope.”
— Dr Chris Rogan
Right now, he’s building the new Department of Interventional Oncology at the Chris O’Brien Lifehouse Cancer Centre, and researching new frontiers like intra-arterial isolation chemotherapy for hard-to-treat cancers like intrahepatic cholangiocarcinoma.
For patients like us, Dr Chris Rogan is more than a specialist.
He’s a great and unassuming asset to the cholangiocarcinoma community — and a quiet force helping us rewrite what’s possible.
More about his work: www.drrogan.com

ICC: A Forgotten Frontier, Reclaimed
“Where the system hesitates, we move.”
— SteveH
Intrahepatic cholangiocarcinoma is hard to treat and easy to overlook. But Dr Rogan is using liver-directed therapies to open new doors — treatments delivered right to the tumour, offering precision, fewer side effects, and faster recovery.
Your Action Point: Ask your care team, “Is liver-directed therapy an option for me?”
This isn’t theoretical — it’s real, and happening now.
Innovation in Action: What Chris Shared
“Execution saves lives. We don’t wait — we can’t.” — SteveH
At APSCVIR, Chris:
Presented his work on liver-targeted therapies for ICC.
Chaired sessions on embolisation — a method to shut off a tumour’s blood supply.
Discussed the increasing use of powerful medical glues (cyanoacrylate) for internal sealing — cutting-edge but complex.
Showcased new applications for bone (MSK) and prostate embolisation — showing how far interventional radiology (IR) can reach.
This wasn’t a pitch. It was proof: IR is expanding what’s possible.
The Global Idea: World IR Awareness Days
“Response is the new standard. Culture is how we win”
— SteveH
Dr Rogan didn’t stop with science. He pitched a global awareness movement — one that gives IR its rightful seat at the treatment table:
World Embolisation Day
World Tumour Ablation Day
World Interventional Radiology Day
“These days aren’t celebrations. They’re catalysts — so patients know what’s possible.”
— Dr Chris Rogan
Brazil has already launched one. Others are considering it. But this is where patients and doctors must lead together.
What This Means for You, Now
“Don’t wait to be rescued. Pick it up. Build with it. Scale it.”
— SteveH
IR is no longer a niche option. For many cancer patients, it may be the least invasive, most targeted path forward. But too often, it’s never mentioned.
Here’s what you can ask:
“Can IR help manage my cancer?”
“Have we looked at embolisation or ablation?”
“Should we bring an IR specialist into my case?”
Awareness isn’t the goal. Empowerment is.
Glossary: What These Words Mean for You
“If we can’t break it down, we can’t understand. If we don’t understand we cant effectively respond and win”
— SteveH
Interventional Radiology (IR)
A medical field that uses imaging (like ultrasound or CT) to guide small tools inside the body — treating conditions without open surgery.
Intrahepatic Cholangiocarcinoma (ICC)
A rare and aggressive cancer that starts in the bile ducts inside the liver.
Liver-Directed Therapy
Treatment delivered straight into the liver — often directly into a tumour — reducing damage to the rest of the body.
Embolisation
A procedure that blocks blood supply to a tumour, starving it of oxygen and slowing or stopping its growth.
Cyanoacrylate Glue
A powerful medical adhesive used to seal blood vessels from the inside — like internal superglue, used with high precision.
MSK Embolisation
Targeted IR treatment to reduce pain or symptoms in bones, joints, or soft tissues.
Prostate Embolisation
A non-surgical procedure to shrink an enlarged prostate by reducing its blood flow.
World IR Awareness Days
Proposed global events like “World Embolisation Day” or “World Tumour Ablation Day” — created to raise visibility and accelerate access to minimally invasive treatments.
Final Word: A Culture That Moves Together
“This isn’t support. It’s infrastructure.”
— SteveH
Dr Chris Rogan exemplifies what happens when a clinician doesn’t wait for approval — but acts. He’s not just leading research. He’s helping reshape how patients receive care.
“This is how survival moves from possibility to execution reality.”
Let’s support that movement — by asking better questions, spreading awareness that builds partnerships like the proposed World IR Days into our advocacy calendar.
Would you like to help champion World IR Day through our Light Australia Green Initiative or during World Cholangiocarcinoma Day?
Let us know. Because awareness doesn’t cure cancer, survival begins with execution of action — and culture strengthens on those who lead.
What Is Cholangio Today?
This is not awareness.
This is not care.
It is the expression and execution of our culture —
a living survival system.
It’s where we patients take the mic —
Not to tell stories.
To lead.
To shape systems.
To spotlight what works.
To share systems that deliver.
To extend response beyond care — through innovation.
This is not support.
This is how we win.
See a blind spot the system keeps missing?
Email: steve@cholangio.org